---
schema_version: "secwatch.filing_event.v1"
accession: "0001156375-23-000015"
form_type: "8-K"
ticker: "CME"
cik: "0001156375"
company_name: "CME GROUP INC."
filed_at: "2023-02-08T23:59:59+00:00"
generated_at: "2026-06-19T21:29:24.455583+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "low"
source: SEC EDGAR
---

# CME Group announces Q4 2022 results; specific figures not available in filing

## Summary
- Press release attached reporting financial results for quarter ended Dec 31, 2022.
- Non-GAAP net income and EPS included as supplemental measures with reconciliation.
- No specific revenue, EPS, or YoY comparisons provided in the filing text.
- CFO John W. Pietrowicz signed the Form 8-K on February 8, 2023.

## SEC filing metadata
- accession: 0001156375-23-000015
- form_type: 8-K
- ticker: CME
- cik: 0001156375
- company_name: CME GROUP INC.
- filed_at: 2023-02-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: low
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000015/0001156375-23-000015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000015/cme-20230208.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001156375-23-000015
- JSON: https://secwatch.observer/filing/0001156375-23-000015.json
- Plain text: https://secwatch.observer/filing/0001156375-23-000015.txt

## Key facts
- Earnings Releases
  CME GROUP INC. reported financial results for the quarter ended December 31, 2022.
  - Period: the quarter ended December 31, 2022
  - Result: reported results
  source text: CME Group Inc.’s financial results for the quarter ended December 31, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1156375/000115637523000015/0001156375-23-000015-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.